Congress routinely conducts hearings, initiates reports and enacts legislation of interest to clinical laboratories. AACC actively participates in this process, meeting with congressional staff, attending hearings, and providing organizational and grassroots input on issues of concern to the association and the field. Please check back periodically to learn about legislative measures of interest to the laboratory community introduced during the 113th Congress. You can obtain copies of the legislation listed below by going to the congressional Web site THOMAS.
House of Representatives
H.R.351, "Protecting Seniors' Access to Medicare Act," would eliminate the Independent Payment Advisory Board created by the Affordable Care Act of 2010. The IPAB will be able to make cuts in Medicare spending without congressional or public input Sponsor: Rep. Phil Roe (R-TN). AACC has endorsed the measure.
H.R.523, "The Protect Medical Innovation Act of 2013," would repeal the 2.3 percent excise tax on medical device manufacturers that took effect on January 1, 2013, as part of health care reform. Sponsor: Rep. Erik Paulsen (R-MN). AACC has endorsed the measure.
H.R.1281, "Newborn Screening Saves Lives Reauthorization Act," would preserve recent advances in state newborn screening programs. In addition to expanding access to newborn screening, H.R.1281 would help state screening programs better assess and coordinate newborn treatments and ensure the quality of testing provided by newborn screening laboratories. AACC endorsed H.R.1281. Sponsors: Rep. Lucille Roybal-Allard (D-CA) and Rep. Michael Simpson (R-ID)
H.R.1701, "Cutting Costly Codes Act of 2013," would prevent the Department of Health and Human Services from adopting the ICD-10 coding system. The bill would also mandate that the General Accountability Office conduct a study to identify steps to reduce any disruptions to health care providers if such a system were adopted. Sponsor: Rep. Ted Poe (R-TX)
H.R.2085, "Diagnostic Innovation Testing and Knowledge Advancement Act of 2013," would create a process for increasing Medicare payments for new laboratory tests. Under the legislation, the Department of Health and Human Services would take into consideration a number of factors when using the gap-fill process to set payment rates for new laboratory tests. Sponsor: Rep. Peter Roskam (R-IL)
S.11, "The Fiscal Sustainability Act of 2013," would streamline the Medicare program and reduce its overall expenditures. Included in the bill is a recommendation to establish a 20 percent copayment for all services, including clinical laboratory testing. Sponsors: Senator Bob Corker (R-TN) and Senator Lamar Alexander (R-TX). AACC opposes a laboratory copayment.
S.232, "Medical Device Access and Innovation Protection Act," would repeal the 2.3 percent excise tax on medical device manufacturers that took effect on January 1, 2013, as part of health care reform. Sponsor: Senator Orrin Hatch (R-UT). AACC has endorsed the measure.